Dr. Kory explains reasons why Labor Premier Annastacia Palaszczuk legislated against Ivermectin
In a recent video, Dr. Pierre Kory, a renowned medical expert, shed light on the reasons behind the decision of Labor Premier Annastacia Palaszczuk to legislate against the use of Ivermectin. The video, which has gone viral, has sparked a heated debate among medical professionals, politicians, and the general public.
Dr. Kory starts by explaining the potential benefits of Ivermectin as a treatment for COVID-19. He highlights numerous studies and real-world evidence that suggest Ivermectin can effectively reduce the severity and mortality of COVID-19. He also emphasizes its safety profile, citing its long history of use in humans and its inclusion on the World Health Organization’s List of Essential Medicines.
However, Dr. Kory argues that certain individuals and organizations, including Premier Palaszczuk, have actively worked to discredit Ivermectin. He suggests that these efforts are driven by various factors, such as financial interests, political agendas, and the desire to maintain control over the narrative surrounding COVID-19.
One of the main reasons Dr. Kory believes Premier Palaszczuk legislated against Ivermectin is the influence of pharmaceutical companies. He claims that these companies have a vested interest in promoting expensive treatments, such as vaccines, instead of inexpensive repurposed drugs like Ivermectin. By legislating against Ivermectin and actively discouraging its use, they can maintain their market share and profitability.
Furthermore, Dr. Kory suggests that politicians like Premier Palaszczuk may be influenced by political considerations. He argues that by aligning themselves with the prevailing narrative, they can gain public support and appear proactive in their response to the pandemic. In this case, Premier Palaszczuk may have chosen to follow the mainstream consensus that Ivermectin is ineffective or unsafe, despite contradictory evidence suggesting otherwise.
Dr. Kory also highlights the role of regulatory bodies, such as the Australian Health Practitioner Regulation Agency (AHPRA) and the Australian Medical Association (AMA), in influencing the decision to legislate
Source link
